These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8652281)

  • 1. Granulocyte-macrophage colony-stimulating factor therapy in patients with chemotherapy-induced aplasia and Clostridium difficile enterocolitis.
    Geiger R; Fussenegger J; Allerberger F; Maurer K; Fink FM
    Eur J Cancer; 1995 Dec; 31A(13-14):2416-7. PubMed ID: 8652281
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Bezwoda WR; Dajee D
    Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
    Doney K; Storb R; Appelbaum FR; Buckner CD; Sanders J; Singer J; Hansen JA
    Br J Haematol; 1993 Sep; 85(1):182-4. PubMed ID: 8251389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the research of clinical use of recombinant human granulocyte colony-stimulating factors].
    Jiang FG; Geng JP; Yang CL
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):723-5. PubMed ID: 1726145
    [No Abstract]   [Full Text] [Related]  

  • 5. The successful treatment of a case of very severe aplastic anaemia with granulocyte-macrophage colony stimulating factor and anti-lymphocyte globulin.
    Potter MN; Mott MG; Oakhill A
    Br J Haematol; 1990 Aug; 75(4):618-9. PubMed ID: 2207014
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of the hematological manifestations of dyskeratosis congenita.
    Putterman C; Safadi R; Zlotogora J; Banura R; Eldor A
    Ann Hematol; 1993 Apr; 66(4):209-12. PubMed ID: 8485209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemopoietic growth factor GM-CSF for aplastic anaemia in children.
    Khan MA; Hameed A; Tahir M; Gandapur AJ; Rehman Hu; Durrani FM; Ahmad A
    Lancet; 1995 Jan; 345(8943):199. PubMed ID: 7823700
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia.
    Gordon-Smith EC; Yandle A; Milne A; Speck B; Marmont A; Willemze R; Kolb H
    Bone Marrow Transplant; 1991; 7 Suppl 2():78-80. PubMed ID: 1878731
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia.
    Kojima S; Fukuda M; Miyajima Y; Matsuyama T
    N Engl J Med; 1990 Sep; 323(13):920-1. PubMed ID: 1697647
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of colony stimulating factors in the treatment of aplastic anemia].
    Domingo Morera JM; Palomera Bernal L; Agulló Alcober JA; Olave Rubio MT
    Med Clin (Barc); 1994 Dec; 103(20):799. PubMed ID: 7532252
    [No Abstract]   [Full Text] [Related]  

  • 15. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.
    Lopez KD; Guinan EC
    Pediatr Nurs; 1995; 21(4):345-9. PubMed ID: 7644282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initiation of hematopoietic recovery by recombinant human granulocyte-macrophage colony-stimulating factor in a case of severe aplastic anemia induced by gold salt].
    Murai K; Michimata M; Shimosegawa K; Oikawa H; Utsugisawa T; Narigasawa Y; Miyairi Y; Kuriya S
    Rinsho Ketsueki; 1995 Jan; 36(1):23-8. PubMed ID: 7715074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
    Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
    Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
    Croockewit AJ; Koopmans PP; de Pauw BE
    Clin Pharmacol Ther; 1996 Jan; 59(1):1-6. PubMed ID: 8549028
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
    Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
    Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.